The Ensign Group, Inc. (ENSG) Financials
ENSG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 4.2 billion | 2.7 billion |
| 2023-09-30 | 4.1 billion | 2.6 billion |
| 2023-06-30 | 4.0 billion | 2.6 billion |
| 2023-03-31 | 3.9 billion | 2.5 billion |
ENSG Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 56.4 million | 8.1 million |
| 2023-09-30 | 97.6 million | 7.2 million |
| 2023-06-30 | 94.8 million | 8.9 million |
| 2023-03-31 | 21.7 million | 6.6 million |
ENSG Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 21.8 million |
| 2023-09-30 | 64.0 million |
| 2023-06-30 | 64.1 million |
| 2023-03-31 | 60.0 million |
ENSG Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 526.9 million | - | 1.7 billion |
| 2023-09-30 | 484.3 million | - | 1.7 billion |
| 2023-06-30 | 440.0 million | - | 1.7 billion |
| 2023-03-31 | 347.1 million | - | 1.8 billion |
ENSG Shares Outstanding
ENSG Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 28.8 million | - | 106.6 million | - |
| 2023-09-30 | 25.7 million | - | 51.1 million | - |
| 2023-06-30 | 25.0 million | - | 53.4 million | - |
| 2023-03-31 | 26.7 million | - | 51.9 million | - |
ENSG Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 980.4 million | 831.8 million |
| 2023-09-30 | 940.8 million | 791.4 million |
| 2023-06-30 | 921.3 million | 772.4 million |
| 2023-03-31 | 886.8 million | 743.0 million |
ENSG
List: Contenders
Price: $116.48
Dividend Yield: 0.00%
Forward Dividend Yield: 0.21%
Payout Ratio: 6.59%
Dividend Per Share: 0.24 USD
Earnings Per Share: 3.65 USD
P/E Ratio: 32.43
Exchange: NMS
Sector: Healthcare
Industry: Medical Care Facilities
Volume: 9451
Ebitda: 38.5 millionMarket Capitalization: 6.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 18
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%